70th CSHL SYMPOSIUM:
MOLECULAR APPROACHES TO
CONTROLLING CANCER
June 1 - 6, 2005
Abstract Deadline: Closed
The Symposium is now oversubscribed. Anyone now registering will be placed on a waiting list. Priority on the waitlist is on a first-come-first-served basis.

Organizers:
Bruce Stillman and David Stewart
Cold Spring Harbor Laboratory

We are pleased to host the 70th Cold Spring Harbor Symposium which will address Molecular Approaches to Controlling Cancer. The Symposium will begin at 7:30 pm on Wednesday, June 1, 2005 and end on the evening of Monday June 6 with normal departure on the following morning.

The Symposium will include 12/13 oral sessions and 2/3 poster sessions covering molecular strategies aimed at understanding and controlling the cancerous state. Most of the talks will be given by invited speakers but we may select a few talks from openly submitted abstracts. Social events throughout the Symposium provide ample opportunity for informal interactions and will include a wine-and-cheese party, a beach picnic, cocktails and banquet, and departure brunch.

Topics:
· Identification of molecular pathways in cancer
· Identification of cancer oncogenes and tumor suppressor genes
· Development and validation of therapeutic targets
· Identification of diagnostic and early detection markers
· Mouse models for human cancer
· Understanding cancer progression and metastasis
· Biology of Cancer Cells & Tissues

Speakers:
Jerry Adams, Walter & Eliza Hall Institute of Medical Research, Australia
James Allison, HHMI/Memorial Sloan Kettering Cancer Center
Mariano Barbacid, Centro Nacional de Investigaciones Oncologica, Spain
Stephen Baylin, Johns Hopkins University School of Medicine
Philip Beachy, Johns Hopkins University School of Medicine
Robert Benezra, Memorial Sloan Kettering Cancer Center
Rene Bernards, Netherlands Cancer Institute
Anton Berns, Netherlands Cancer Institute
J. Michael Bishop, University of California, San Francisco
Mina Bissell, Lawrence Berkeley National Laboratory
Himanshu Brahmbhatt, EnGeneIC Pty Ltd
Joan Brugge, Harvard Medical School
Judith Campisi, Lawrence Berkeley National Laboratory
Sara Courtneidge, Van Andel Research Institute
Titia de Lange, The Rockefeller University
Ronald DePinho, Dana Farber Cancer Institute
Robert Eisenman, Fred Hutchinson Cancer Research Center
Stephen Elledge, Harvard Medical School
Gerard Evan, University of California, San Francisco
Andrew Feinberg, Johns Hopkins University School of Medicine
Judah Folkman, Children's Hospital /Harvard Medical School
Stephen Friend, Merck Research Laboratories
Andrew Futreal, Wellcome Trust Sanger Institute
Denise Galloway, Fred Hutchinson CRC, Seattle
Joe Gray, Lawrence Berkeley National Laboratory
Carol Greider, Johns Hopkins University School of Medicine
Daniel Haber, Massachusetts General Hospital
Douglas Hanahan, University of California, San Francisco
Greg Hannon, Cold Spring Harbor Laboratory
Ed Harlow, Harvard Medical School
James Herman, Johns Hopkins University
Kenneth Hillan, Genentech, Inc.
Tyler Jacks, HHMI/Massachusetts Institute of Technology
William Kaelin, Dana-Farber Cancer Institute/HMS
Raghu Kalluri, Beth Israel Deaconess Medical Center
Michael Kastan, St. Jude Children's Research Hospital
Mary-Claire King, University of Washington
David Lane, University of Dundee, UK
Jacqueline Lees, Massachusetts Institute of Technology
Arnold Levine, Institute for Advanced Studies, Princeton
Lance Liotta, National Cancer Institute
David Livingston, Dana-Farber Cancer Institute/HMS
Scott Lowe, Cold Spring Harbor Laboratory
Joan Massague, Memorial Sloan Kettering Cancer Center
Frank McCormick, University of California, San Francisco
Matthew Meyerson, Dana-Farber Cancer Institute/HMS
Sean Morrison, University of Michigan
Pier-Paolo Pandolfi, Memorial Sloan-Kettering Cancer Center
Luis Parada, UT Southwestern Medical Center
Nikola Pavletich, Memorial Sloan Kettering Cancer Center
Carol Prives, Columbia University
Terrance Rabbitts, MRC
Charles Sawyers, University of California, Los Angeles
William Sellers, Dana-Farber Cancer Institute/HMS
Manuel Serrano, Spanish National Cancer Center (CNIO)
Charles Sherr, HHMI/St. Jude Children's Research Hospital
Dennis Slamon, University of California, Los Angeles
Craig Thompson, University of Pennsylvania
Thea Tlsty, University of California, San Francisco
David Tuveson, University of Pennsylvania, Philadelphia
Terry Van Dyke, University of North Carolina at Chapel Hill
Maarten Van Lohuizen, Netherlands Cancer Institute
Harold Varmus, Memorial-Sloan Kettering Cancer Center
Robert Weinberg, Whitehead Institute for Biomedical Research
Zena Werb, University of California, San Francisco
Michael Wigler, Cold Spring Harbor Laboratory
Owen Witte, University of California, Los Angeles
Paul Workman, Cancer Research UK/ICR
George Yancopoulos, Regeneron Pharmaceuticals, Inc.

We are accepting abstracts for consideration as poster presentations. Abstracts should contain only new and unpublished material and must be submitted electronically by the abstract deadline. Status of abstracts will be posted on our web site as soon as decisions have been made by the organizers.

We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. Apply in writing to meetings@cshl.edu stating need for financial support - preference is given to those submitting abstracts.

We look forward to seeing you at Cold Spring Harbor in June.

This conference is supported in part by funds provided by CSHL's Corporate Sponsor Program and the National Cancer Institute.

---

Regular packages are all inclusive and cover registration, food, housing, parking, wine-and-cheese party, lobster banquet, etc. No Housing packages include all costs except housing. Full payment is due 4 weeks prior to the meeting.